SLR Investment Corp
NASDAQ:SLRC

Watchlist Manager
SLR Investment Corp Logo
SLR Investment Corp
NASDAQ:SLRC
Watchlist
Price: 14.98 USD -0.13% Market Closed
Market Cap: $817.2m

SLR Investment Corp
Investor Relations

SLR Investment Corp. is a closed-end, externally managed, non-diversified management investment company. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2010-02-09. The firm invests primarily in privately held United States middle-market companies. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests primarily invests directly and indirectly in leveraged, U. S. middle market companies in the form of cash flow senior secured loans including first lien and second lien debt instruments and asset-based loans including senior secured loans collateralized on a first lien basis primarily by current assets. In addition, it invests in foreign markets, including emerging markets. Its investments generally range between $ five million and $100 million each. The company also invests a portion of its portfolio in other types of investments, such as opportunistic investments. The firm's investment manager is SLR Capital Partners, LLC.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 5, 2025
AI Summary
Q3 2025

Stable Portfolio: SLR Investment Corp reported portfolio stability and resilience, with net asset value per share slightly up quarter-over-quarter and flat year-over-year.

Income & Dividend: Net investment income was $0.40 per share, just under the $0.41 per share base dividend; net income was $0.43 per share.

Specialty Finance Focus: The company continued its shift toward specialty finance and asset-based lending, now representing about 83% of the loan portfolio.

Strong ABL Growth: Asset-based lending originations were robust, with ABL portfolio totaling $1.4 billion and record new originations despite some market churn.

Credit Quality: Portfolio quality remained high with 99.5% of debt investments performing and only one investment on nonaccrual.

Liquidity & Capital: Over $850 million of available capital at quarter end, with a net debt-to-equity ratio of 1.13x, leaving room for further leverage.

Distribution Declared: Q4 2025 base distribution of $0.41 per share was declared, with management monitoring dividend sustainability.

Cost & Expenses: A slight uptick in G&A expense this quarter was attributed to a onetime accrual true-up; run rate expected to normalize.

Key Financials
Net Investment Income Per Share
$0.40
Net Income Per Share
$0.43
Net Asset Value Per Share
$18.21
Net Asset Value
$993.3 million
Quarterly Base Distribution
$0.41 per share
Gross Investment Income
$57 million
Net Expenses
$35.4 million
Net Increase in Net Assets from Operations
$23.3 million
Available Capital
$850 million
Net Debt-to-Equity Ratio
1.13x
Portfolio Fair Market Value
$2.1 billion (on-balance sheet)
Number of Portfolio Companies
109
Annualized Return on Equity
9.4%
New Originations (Q3)
$447 million
Repayments (Q3)
$419 million
Asset-Based Lending Portfolio
$1.4 billion
Weighted Average Yield (Total Portfolio)
12.2%
Weighted Average Yield (ABL Portfolio)
13.4%
Weighted Average Yield (Equipment Finance)
11.4%
Weighted Average Yield (Life Sciences Portfolio)
12.3%
Cash Flow Portfolio
$500 million
Weighted Average Yield (Cash Flow Portfolio)
10.2%
First Lien Senior Secured Loans (Portfolio %)
94.8%
Performing Debt Investments (Cost Basis)
99.5%
Performing Debt Investments (Fair Value Basis)
99.7%
Life Sciences Portfolio
$218 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Michael Stuart Gross
Chairman, President & Co-CEO
No Bio Available
Mr. Bruce John Spohler
Co-CEO, COO & Interested Director
No Bio Available
Mr. Shiraz Y. Kajee C.P.A.
CFO & Treasurer
No Bio Available
Mr. Richard R. Pivirotto Jr.
Investor Relations
No Bio Available
Mr. Guy Francis Talarico J.D.
Corporate Secretary & Chief Compliance Officer
No Bio Available
Mr. Anthony Storino
Head of Healthcare Venture Lending
No Bio Available

Contacts

Address
NEW YORK
New York City
500 Park Avenue, 3Rd Floor
Contacts